Roivant Sciences Ltd (ROIV)

05:51 AM

Guggenheim raises Roivant Sciences stock price target to $25 on pipeline progress - Investing.com India

05:51 AM

04:44 AM

Is Roivant Sciences Ltd. (87S) stock a momentum leaderOptions Play & Low Volatility Stock Recommendations - newser.com

04:44 AM

04:11 AM

Best data tools to analyze Roivant Sciences Ltd. stock2025 Institutional Moves & Growth Focused Investment Plans - newser.com

04:11 AM

04:06 AM

How to forecast Roivant Sciences Ltd. trends using time seriesPortfolio Gains Summary & Reliable Intraday Trade Alerts - newser.com

04:06 AM

04:04 AM

Can Roivant Sciences Ltd. (87S) stock survive global slowdownJuly 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com

04:04 AM

02:26 AM

Can Roivant Sciences Ltd. (87S) stock resist broad market declinesDip Buying & Fast Gain Stock Tips - newser.com

02:26 AM

Nov 13, 2025

Real time breakdown of Roivant Sciences Ltd. stock performanceBull Run & Smart Allocation Stock Tips - newser.com

Nov 13, 2025

Nov 13, 2025

Roivant Sciences: Brepocitinib And Roadmap Still Underpriced (NASDAQ:ROIV) - Seeking Alpha

Nov 13, 2025

Nov 13, 2025

Can Roivant Sciences Ltd. rally from current levelsJobs Report & Daily Momentum Trading Reports - newser.com

Nov 13, 2025

Nov 13, 2025

Roivant Sciences (ROIV): Evaluating Valuation After Earnings, Pipeline Wins, and Legal Milestone - simplywall.st

Nov 13, 2025

Nov 12, 2025

Is Roivant Sciences Ltd. (87S) stock safe for risk averse investorsTrade Analysis Summary & Real-Time Market Sentiment Alerts - newser.com

Nov 12, 2025

Nov 12, 2025

Roivant Sciences Hits New 52-Week High of $20.77, Up 94.9% Year-to-Date - Markets Mojo

Nov 12, 2025

Nov 11, 2025

Citigroup Maintains Roivant Sciences (ROIV) Buy Recommendation - Nasdaq

Nov 11, 2025

Nov 11, 2025

Looking Into Roivant Sciences Ltd's Recent Short Interest - Benzinga

Nov 11, 2025

Nov 11, 2025

Roivant Sciences at Guggenheim Conference: Strategic Pipeline Focus - Investing.com India

Nov 11, 2025

Nov 11, 2025

Transcript : Roivant Sciences Ltd. Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference, Nov-11-2025 08 - MarketScreener

Nov 11, 2025

Nov 11, 2025

Roivant Sciences at Guggenheim Conference: Strategic Pipeline Focus By Investing.com - Investing.com Australia

Nov 11, 2025

Nov 11, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2026 Earnings Call Transcript - Insider Monkey

Nov 11, 2025

Nov 11, 2025

Will Roivant Sciences Ltd. stock gain from government policies2025 Trade Ideas & Daily Profit Focused Stock Screening - newser.com

Nov 11, 2025

Nov 11, 2025

ROIV Crosses Above Average Analyst Target - Nasdaq

Nov 11, 2025

Nov 11, 2025

Leerink Partners raises Roivant Sciences stock price target to $29 on model extension - Investing.com Australia

Nov 11, 2025

Nov 11, 2025

Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Lags Revenue Estimates - sharewise.com

Nov 11, 2025

Nov 10, 2025

Roivant Sciences Reports Q2 2025 Financial Results - TipRanks

Nov 10, 2025

Nov 10, 2025

ROIV SEC FilingsRoivant Sciences 10-K, 10-Q, 8-K Forms - Stock Titan

Nov 10, 2025

Nov 10, 2025

Is Roivant Sciences Ltd. (87S) stock prepared for digital transition2025 Earnings Impact & High Accuracy Investment Signals - newser.com

Nov 10, 2025

Nov 10, 2025

Will Roivant Sciences’ (ROIV) Slowing Revenue Growth Shape Its Long-Term Innovation Story? - Yahoo Finance

Nov 10, 2025

Nov 10, 2025

Roivant Sciences earnings beat by $0.15, revenue fell short of estimates - Investing.com South Africa

Nov 10, 2025

Nov 10, 2025

Roivant Sciences (ROIV) PT Raised to $26 at Citi - StreetInsider

Nov 10, 2025

Nov 10, 2025

Roivant Sciences Ltd (ROIV) Q2 2025 Earnings Call Highlights: Strong Financial Position and ... By GuruFocus - Investing.com Canada

Nov 10, 2025

Nov 10, 2025

Roivant Sciences Q2 2026 Earnings Call Transcript - MarketBeat

Nov 10, 2025

Nov 10, 2025

Roivant Sciences Ltd. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ROIV) 2025-11-10 - Seeking Alpha

Nov 10, 2025

Nov 10, 2025

Earnings call transcript: Roivant Sciences Q2 2026 beats EPS forecast - Investing.com

Nov 10, 2025

Nov 10, 2025

Earnings call transcript: Roivant Sciences Q2 2026 beats EPS forecast By Investing.com - Investing.com Australia

Nov 10, 2025

Nov 10, 2025

Roivant Sciences Ltd. (ROIV) Tops Q2 EPS by 15c - StreetInsider

Nov 10, 2025

Nov 10, 2025

Roivant Sciences' Fiscal Q2 Net Loss Narrows, Revenue Falls - MarketScreener

Nov 10, 2025

Nov 10, 2025

Roivant Sciences Ltd. SEC 10-Q Report - TradingView

Nov 10, 2025

Nov 10, 2025

[8-K] Roivant Sciences Ltd. Reports Material Event | ROIV SEC FilingForm 8-K - Stock Titan

Nov 10, 2025

Nov 10, 2025

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update - The Manila Times

Nov 10, 2025